NEWS

Exclusive License Agreement with HKU TTO for the patent for develop, make and sell the licensed products related to the Antibody against PD-1 Isoforms for cancer and inflammatory diseases

Hong Kong Scientists Make Potential HIV Treatment Breakthrough

Learn More

Exclusive License Agreement with HKU TTO for the patent of PD-1-based DNA vaccine for prevention and treatment of HIV

Study sheds light on cancer prevention and immunotherapy

Learn More

港大研發抗腫瘤疫苗方法

Learn More